Interestingly, one study found that IDH1 and IDH2 mutant AML cells produce the metabolite R-2HG that rapidly increases intracellular ROS, which in turn affects NF-κB protein stability and transcriptional activity (Chen et al., 2016). This evidence concerns the gene IDH1 and acute myeloid leukemia.